Bassam Damaj Insider Profile
4 Followers
Bassam Damaj, President & CEO, Director at Seelos Therapeutics, holds 1.61M shares in Seelos Therapeutics (Ticker: SEELQ).
Bassam Damaj's Trading History
| SEELQSeelos Therapeutics | Aug 23, 2012 | President & CEO, Director | Uninformative Buy | ― | ― | |
SEELQ Insider Shares: 1.61M (3.20%) | ||||||
You May Also Like
Bassam Damaj insider profile FAQ
What is the percentage of profitable transactions made by Bassam Damaj?
The percentage of profitable transactions made by Bassam Damaj is 0%.
What is the average return per transaction made by Bassam Damaj?
The average return per transaction made by Bassam Damaj is -18.90%.
What stocks does Bassam Damaj hold?
Bassam Damaj holds: SEELQ stocks.
What was Bassam Damaj's most profitable transaction?
Bassam Damaj’s most profitable transaction was an Informative Buy of SEELQ stock on August 23, 2012. The return on the trade was -17.10%.
What is Bassam Damaj's role in Seelos Therapeutics?
Bassam Damaj's role in Seelos Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
